-
Is the new crown vaccine every year?
Time of Update: 2021-06-10
Focusing on hot topics such as epidemic prevention and control and vaccination of public concern, experts such as Zhang Wenhong, Zheng Zhongwei, Li Lanjuan and others who came to the conference conducted discussions and exchanges and made the latest judgments.
-
Academician Chen Wei: Nebulized and inhaled new crown vaccine is applying for emergency use
Time of Update: 2021-06-10
" Academician Chen Wei recalled the development and marketing of recombinant new crown virus vaccines.
-
Zhang Wenhong: Vaccination is the "invisible protector" behind modern people
Time of Update: 2021-06-10
" Zhang Wenhong said that the mechanism of herd immunity is to allow the vast majority of people to receive vaccination.
-
The State Food and Drug Administration approves the world's first ARNI hypertension indication
Time of Update: 2021-06-10
The results of a phase III clinical study led by Professor Yong Huo from Peking University First Hospital and vice chairman of the Chinese Cardiovascular Health Alliance showed that the blood pressure lowering effect of sacubitril and valsartan after 8 weeks of treatment was significantly better than that of ARB drugs In the control group with the best antihypertensive effect, it can significantly improve the patient's blood pressure compliance rate.
-
Professor Xie Rong, a famous anesthesiologist and medical educator in my country, dies
Time of Update: 2021-06-10
Members of the committee members A farewell ceremony for the body of Professor Xie Rong is scheduled to be held at the funeral home of Peking University First Hospital at 7:00 am on June 7, 2021 (Monday).
-
The expense structure of A-share listed pharmaceutical companies in 2020 will be further optimized
Time of Update: 2021-06-10
From the perspective of the cost composition of listed A-share pharmaceutical companies, the proportion of sales expenses is at a high level throughout the year.
From the perspective of the cost composition of listed A-share pharmaceutical companies, the proportion of sales expenses is at a high level throughout the year.
-
These drugs will be "prescription outflow" and another province will start pilot projects!
Time of Update: 2021-06-10
The Hunan Provincial Health Commission requires relevant medical institutions to complete the interface upgrade and transformation of the institution's HIS system as required, complete the docking with the prescription circulation and supervision platform, and realize the functions of real-time upload of prescription information and electronic signature and certification of physicians and pharmacists.
-
Sichuan pharmaceutical company will win the blockbuster first imitation of $1.4 billion varieties to welcome the first production company
Time of Update: 2021-06-10
)Recently, the first generic drug R&D welcome progress: Hainan Simcere is the first to submit a generic drug listing application for idoxaban tosylate tablets, and Sichuan Pride Times Pharmaceuticals uses generic 3 types of telmisartan and amlodipine tablets for production Enter the stage of administrative approval.
-
Does the new crown inactivated vaccine need a third shot?
Time of Update: 2021-06-10
State Council Yin Weidong pointed out that the country has now approved the emergency use of Kexing's new crown vaccine to expand the age range to over 3 years old, but when the vaccine will be used in a lower age group, relevant experts will be organized by the National Health Commission according to China's current epidemic needs and population.
-
"Dual channel" is good for DTP pharmacy!
Time of Update: 2021-06-10
"Dual channel" is so good for DTP pharmacies The first batch of 19 drugs belong to the main business scope of DTP Although the issue of drug availability caused by the "difficulty in hospital admission" of negotiated products is a common problem in all new medical insurance products, from the perspective of the impact on patients, the availability of oncology drugs and drugs for rare diseases is obviously more important.
-
Health Commission: 19 new confirmed cases and 5 local cases
Time of Update: 2021-06-10
As of 24:00 on June 6, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 403 confirmed cases (including 10 severe cases), 86,228 cured and discharged cases, and 4,636 deaths.
-
China Resources Double Crane: the first domestic irbesartan dispersible tablet to pass the consistency evaluation
Time of Update: 2021-06-10
On June 4, China Resources Double Crane announced that the first domestic dispersible tablet of Irbesartan passed the consistency evaluation.
As of the date of this announcement, Shuanghe Limin has invested a total of RMB 6,730,500 (unaudited) in the research and development of the drug's consistency evaluation.
-
National Food and Drug Administration: List of 109 National Innovative Medical Devices
Time of Update: 2021-06-10
The Medical Device Evaluation Center of the State Drug Administration (hereinafter referred to as "CMDE") as the implementing unit, through cooperation with the Chinese Society of Biomedical Engineering and the Chinese Society for Biomaterials, with the help of the society’s rich expert resources, select authoritative experts and scholars in relevant research fields to pass The meeting method put forward review opinions.
-
Smeglutide has been approved by the FDA for weight loss indications!
Time of Update: 2021-06-10
The Phase IIIa study included 4 trials, enrolling a total of approximately 4,500 overweight or obese adult patients, of which:The STEP 1 study (adjuvant life>The results showed that after 68 weeks of treatment with smeglutide, the intention-to-treat patients lost 16.
-
24 new cases were confirmed on the 4th, including 11 local cases
Time of Update: 2021-06-10
As of 24:00 on June 4, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 385 confirmed cases (including 9 severe cases), a total of 86,197 cured and discharged cases, and a total of 4,636 deaths.
-
From GPO to national procurement, analysis of changes in the market structure of large varieties!
Time of Update: 2021-06-10
Valaciclovir Hydrochloride Tablets In October 2016, Shanghai announced the results of the second batch of GPO winning bids, showing that there are two bidding companies for valacyclovir hydrochloride tablets, namely Shanghai Shangyao Xinyi and Chengdu Beite.
-
American virologist: The possibility that the new crown will come from the laboratory is almost non-existent
Time of Update: 2021-06-10
Peter Dasak, Chairman of the American Ecological Health Alliance: During the 15 years of working with Wuhan Institute of Virology, everything I learned is what is happening in the virus laboratory.
-
How to speed up the vaccination of Kexing Vaccine after entering the WTO?
Time of Update: 2021-06-10
On June 1, local time, the World Health Organization announced that China's Kexing new crown vaccine was included in the "emergency use list.
Now the country has approved the emergency use of Kexing's new crown vaccine to expand the age range to over 3 years old, but what is the vaccine?
-
Research finds that women's risk of dementia increases with blood pressure
Time of Update: 2021-06-10
Xinhua News Agency, Sydney, June 6 (Li Xinyu) A recent Australian study found that blood pressure has different effects on the risk of dementia in men and women.
-
Health Commission: 30 new confirmed cases and 7 local cases
Time of Update: 2021-06-10
As of 24:00 on June 5, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 392 confirmed cases (including 10 severe cases), 86,220 cured and discharged cases, and 4,636 deaths.
